Mutant presenilin 2 transgenic mouse: Effect on an age-dependent increase of amyloid β-protein 42 in the brain

Journal of Neurochemistry

Volumn 71, Issue 1, 1998, Pages 313-322

  Oyama, Fumitaka ^a   Sawamura, Naoya ^a   Kobayashi, Kimio ^b   Morishima Kawashima, Maho ^a   Kuramochi, Takashi ^b   Ito, Mamoru ^b   Tomita, Taisuke ^c   Maruyama, Kei ^d   Saido, Takaomi C ^e   Iwatsubo, Takeshi ^c   Capell, Anja ^f   Walter, Jochen ^f   Grünberg, Jürgen ^f   Ueyama, Yoshito ^b,g   Haass, Christian ^f   Ihara, Yasuo ^a,h  

^a TOTTORI UNIVERSITY   (Japan)

^b CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

^e TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^f CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^g TOKAI UNIVERSITY   (Japan)

^h UNIVERSITY OF TOKYO   (Japan)

Author keywords

Alzheimer's disease; Amyloid protein; Presenilin 2; Transgenic mouse

Indexed keywords

AMYLOID BETA PROTEIN; MESSENGER RNA; MUTANT PROTEIN; PRESENILIN 2;

ADOLESCENT; AGE; ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE OVEREXPRESSION; MISSENSE MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 18544411933     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71010313.x     Document Type: Article

References (37)

1. Asami-Odaka A., Ishibashi Y., Kikuchi T., Kitada C., and Suzuki N. (1995) Long amyloid β-protein secreted from wild-type human neuroblastoma IMR-32 cells. Biochemistry 34, 10272-10278.
2. Borchelt D. R., Thinakaran G., Eckman C. B., Lee M. K., Davenport F., Ratovitsky T., Prada C.-M., Kim G., Eekins S., Yager D., Slunt H. H., Wang R., Seeger M., Levey A. I., Gandy S. E., Copeland N. G., Jenkins N. A., Price D. L., Younkin S. G., and Sisodia S. S. (1996) Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. Neuron 17, 1005-1013.
3. Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 120-129.
4. Citron M., Westaway D., Xia W., Carlson G., Diehl T., Levesque G., Johnson-Wood K., Lee M., Seubert P., Davis A., Kholodenko D., Motter R., Sherrington R., Perry B., Yao H., Strome R., Lieberburg I., Rommens J., Kim S., Schenk D., Fraser P., St. George-Hyslop P., and Selkoe D. J. (1996) Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nat. Med. 3, 67-72.
5. Duff K., Eckman C., Zehr C., Yu X., Prada C.-M., Perez-tur J., Hutton M., Buee L., Harigaya Y., Yager D., Morgan D., Gordon M. N., Holcomb L., Refolo L., Zenk B., Hardy J., and Younkin S. (1996) Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710-713.
6. Glenner G. G. and Wong C. E. (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890.
7. Gravina S. A., Ho L., Eckman C. B., Long K. E., Otvos L. Jr., Younkin L. H., Suzuki N., and Younkin S. G. (1995) Amyloid β protein (Aβ) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at Aβ 40 or Aβ 42(43). J. Biol. Chem. 270, 7013-7016.
8. Gu Y., Oyama F., and Ihara Y. (1996) τ is widely expressed in rat tissues. J. Neurochem. 67, 1235-1244.
9. Haass C. (1997) Presenilins: genes for life and death. Neuron 18, 687-690.
10. Ishizawa M., Kobayashi Y., Miyamura T., and Matsuura S. (1991) Simple procedure of DNA isolation from human serum. Nucleic Acids Res. 19, 5792.
11. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., and Ihara Y. (1994) Visualization of Aβ 42(43) and Aβ 40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ 42(43). Neuron 13, 45-53.
12. Iwatsubo T., Mann D. M. A., Odaka A., Suzuki N., and Ihara Y. (1995) Amyloid β protein (Aβ) deposition: Aβ 42(43) precedes Aβ 40 in Down syndrome. Ann. Neurol. 37, 294-299.
13. Jarrett J. T., Berger E. P., and Lansbury P. T. Jr. (1993) The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693-4697.
14. Kang J., Lemaire H. G., Unterbeck A., Salbaum J. M., Masters C. L., Grzeschik K. H., Multhaup G., Beyreuther K., and Müller-Hill B. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736.
15. Kim T.-W., Pettingel W. H., Hallmark O. G., Moir R. D., Wasco W., and Tanzi R. E. (1997a) Endoproteolytic cleavage and proteasomal degradation of presenilin 2 in transfected cells. J. Biol. Chem. 272, 11006-11010.
16. Kim T.-W., Pettingel W. H., Jung Y.-K., Kovacs D. M., and Tanzi R. E. (1997b) Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science 277, 373-376.
17. Koo E. H. and Squazzo S. L. (1994) Evidence that production and release of amyloid β-protein involves the endocytic pathway. J. Biol. Chem. 269, 17386-17389.
18. Kosaka T., Imagawa M., Seki K., Arai H., Sasaki H., Tsuji S., Asami-Odaka A., Fukushima T., Imai K., and Iwatsubo T. (1997) The βAPP717 Alzheimer mutation increases the percentage of plasma amyloid-β protein ending at Aβ42(43). Neurology 48, 741-745.
19. Kovacs D. M., Fausett H. J., Page K. J., Kim T. W., Moir R. D., Merriam D. E., Hollister R. D., Hallmark O. G., Mancini R., Felsenstein K. M., Hyman B. T., Tanzi R. E., and Wasco W. (1996) Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat. Med. 2, 224-229.
20. Levy-Lahad E., Wijsman E. M., Nemens E., Anderson L., Goddard K. A. B., Weber J. L., Bird T. D., and Schellenberg G. D. (1995a) A familial Alzheimer's disease locus on chromosome 1. Science 269, 970-973.
21. Levy-Lahad E., Wasco W., Poorkaj P., Romano D. M., Oshima J., Pettingell W. H., Yu C.-E., Jondro P. D., Schmidt S. D., Wang K., Crowley A. C., Fu Y.-H., Guenette S. Y., Galas D., Nemens E., Wijsman E. M., Bird T. D., Schellenberg G. D., and Tanzi R. E. (1995b) Candidate gene for the chromosome 1 familial Alzheimer' disease locus. Science 269, 973-977.
22. Masters C. L., Simms G., Weisman N. A., Multhaup G., McDonald B. L., and Beyreuther K. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82, 4245-4249.
23. Niwa H., Yamamura K., and Miyazaki J. (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108, 192-200.
24. Rogaev E. I., Sherrington R., Rogaeva E. A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., Tsuda T., Mar L., Sorbi S., Nacmias B., Piacentini S., Amaducci L., Chumakov I., Cohen D., Lannfelt L., Fraser P. E., Rommens J. M., and St. George-Hyslop P. H. (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775-778.
25. Roher A. E., Lowenson J. D., Clarke S., Wolkow C., Wang R., Cotter R. J., Reardon I. M., Zurcher-Neely H. A., Heinrikson R. L., Ball M. J., and Greenberg B. D. (1993) Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J. Biol. Chem. 268, 3072-3083.
26. Schellenberg G. D., Bird T. D., Wijsman E. M., Orr H. T., Anderson L., Nemens E., White J. A., Bonnycastle L., Weber J. L., Alonso M. E., Potter H., Heston L. L., and Martin G. M. (1992) Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 258, 668-671.
27. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T. D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Vittanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., and Younkin S. (1996) Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2, 864-870.
28. Sherrington R., Rogaev E. I., Liang Y., Rogaeva E. A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J.-F., Bruni A. C., Montesi M. P., Sorbi S., Rainero I., Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Sanseau P., Polinsky R. J., Wasco W., Da Silva H. A. R., Haines J. L., Pericak-Vance M. A., Tanzi R. E., Roses A. D., Fraser P. E., Rommens J. M., and St. George-Hyslop P. H. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760.
29. Suzuki N., Cheung T. T., Cai X.-D., Odaka A., Otvos L. Jr., Eckman C., Golde T. E., and Younkin S. G. (1994a) An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants. Science 264, 1336-1340.
30. Suzuki N., Iwatsubo T., Odaka A., Ishibashi Y., Kitada C., and Ihara Y. (1994b) High tissue content of soluble β 1-40 is linked to cerebral amyloid angiopathy. Am. J. Pathol. 145, 452-460.
31. Tomita T., Maruyama K., Saido T. C. Kume H., Shinozaki K., Tokuhiro S., Capell A., Walter J., Grünberg J., Haass C., Iwatsubo T., and Obata K. (1997) The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid β protein ending at the 42nd (or 43rd) residue. Proc. Natl. Acad. Sci. USA 94, 2025-2030.
32. Vassilacopoulou D., Ripellino J. A., Tezapsidis N., Hook V. Y. H., and Robakis N. K. (1995) Full-length and truncated Alzheimer amyloid precursors in chromaffin granules: solubilization of membrane amyloid precursor is mediated by an enzymatic mechanism. J. Neurochem. 64, 2140-2146.
33. 2+-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science 271, 521-525.
34. Vito P., Wolozin B., Ganjei J. K., Iwasaki K., Lacanà E., and D'Adamio L. (1996b) Requirement of the familial Alzheimer's disease gene PS2 for apoptosis. Opposing effect of ALG-3. J. Biol. Chem. 271, 31025-31028.
35. Vito P., Ghayur T., and D'Adamio L. (1997) Generation of antiapoptotic presenilin-2 polypeptides by alternative transcription, proteolysis, and caspase-3 cleavage. J. Biol. Chem. 272, 28315-28320.
36. Walter J., Capell A., Grünberg J., Pesold B., Schindzielorz A., Prior R., Podlisny M. B., Fraser P., St. George-Hyslop P., Selkoe D. J., and Haass C. (1996) The Alzheimer's disease-associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum. Mol. Med. 2, 673-691.
37. Wolozin B., Iwasaki K., Vito P., Ganjei J. K., Lacanà E., Sunderl T., Zhao B., Kusiak J. W., Wasco W., and D'Adamio L. (1996) Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science 274, 1710-1713.